Alerting Providers at Patient Hospital Discharge to Consider Prescribing Rivaroxaban to Reduce Venous Thromboembolism

Conditions: Venous Thromboembolic Disease; Pulmonary Embolism and Thrombosis; Deep Vein Thrombosis; Hospitalism Interventions: Other: EHR (electronic health record) alert; Other: No EHR (electronic health record) alert Sponsors: Scott C. Woller, MD; Janssen Pharmaceuticals Not yet recruiting

https://clinicaltrials.gov/study/NCT06232551

Source: ClinicalTrials.gov - January 30, 2024 Category: Research Source Type: clinical trials